Important: The POPLINE website will retire on September 1, 2019. Click here to read about the transition.

Extended effectiveness of the Etonogestrel-releasing contraceptive implant and the 20 ug Levonorgestrel-releasing intrauterine system for 2 years beyond U.S. Food and Drug Administration Product Labeling.

Author: 
Ali M; Bahamondes L; Landoulsi SB
Source: 
Global Health: Science and Practice. 2017 Dec; 5(4):534-539.
Language: 
Year: 
Region / Country: 
Document Number: 
379364
Add to my documents. Add to My Documents